ABVC BioPharma, Inc.
ABVC
$2.41
-$0.12-4.74%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -43.29% | 108.70% | -30.60% | 50.38% | 4.10% |
| Total Receivables | 89.45% | 164.83% | -53.50% | -5.04% | -4.24% |
| Inventory | 0.00% | 0.00% | -- | -- | -- |
| Prepaid Expenses | 129.38% | 102.28% | 0.21% | 5.37% | -9.42% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -3.82% | 13.29% | -1.30% | -2.70% | 2.26% |
| Total Current Assets | 47.00% | 88.51% | -32.58% | 1.47% | -1.89% |
|
|
|||||
| Total Current Assets | 47.00% | 88.51% | -32.58% | 1.47% | -1.89% |
| Net Property, Plant & Equipment | 43.23% | -0.32% | 655.73% | -86.36% | -1.14% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -1.24% | 0.73% | -0.31% | 26.49% | 0.72% |
| Total Assets | 30.39% | 9.18% | 97.29% | -47.87% | -1.17% |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | -1.66% | 3.28% | -6.54% | 0.84% | -3.78% |
| Short-term Debt | 33.29% | -5.02% | -6.19% | 31.93% | 8.10% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -17.88% | -48.20% | -10.26% | 0.09% | 1.08% |
| Total Finance Division Other Current Liabilities | -19.69% | 41.17% | 159.99% | -26.35% | -28.02% |
| Total Other Current Liabilities | -19.69% | 41.17% | 159.99% | -26.35% | -28.02% |
| Total Current Liabilities | -0.38% | -2.94% | 2.64% | 3.83% | -3.56% |
|
|
|||||
| Total Current Liabilities | -0.38% | -2.94% | 2.64% | 3.83% | -3.56% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 33.29% | -5.02% | -6.19% | 31.93% | 8.10% |
| Capital Leases | -7.34% | 6.05% | -29.48% | 66.53% | -37.85% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -71.22% | 92.17% | 0.00% | -15.56% | -7.22% |
| Total Liabilities | -1.00% | -2.43% | 1.52% | 5.13% | -4.73% |
|
|
|||||
| Common Stock & APIC | 7.80% | 3.31% | 6.39% | -9.98% | 0.26% |
| Retained Earnings | -1.73% | -3.23% | -1.22% | 2.27% | -0.27% |
| Treasury Stock & Other | -6.14% | 13.03% | -0.02% | -0.27% | 0.30% |
| Total Common Equity | 71.92% | 29.78% | 340.78% | -85.33% | 0.78% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 71.92% | 29.78% | 340.78% | -85.33% | 0.78% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -1.66% | -2.97% | 608.14% | -32.47% | 18.51% |
| Total Equity | 52.72% | 19.27% | 998.94% | -90.93% | 1.93% |
|
|
|||||